Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3684032014 | Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3684033016 | Xylometazoline hydrochloride 344.48 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4603691000052113 | xylometazolinhydroklorid 344,48 milligram, oral kapsel | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing xylometazoline (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Xylometazoline hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Bronchodilator (substance) | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Capsule | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing xylometazoline in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has active ingredient | Xylometazoline hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Xylometazoline hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | har täljarvärde som visar styrka | 344,48 | false | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Xylometazoline hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing only xylometazoline in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing alpha adrenergic receptor agonist (product) | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing adrenergic receptor agonist (product) | false | Inferred relationship | Some | ||
| Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Product containing imidazole (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR